hnRNPA2/B1 activates cyclooxygenase-2 and promotes tumor growth in human lung cancers

Transformation from NSCLC to SCLC: when did it happen?

(2015) Baoqing Chen et al.   LANCET ONCOLOGY

COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion

(2014) Xin Qiu et al.   ENDOCRINE-RELATED CANCER

Impact ofCOX2genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients

(2014) Andrea Markkula et al.   INTERNATIONAL JOURNAL OF CANCER

Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study

(2014) Faisal Aziz et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Apoptotic Effects of Two COX-2 Inhibitors on Breast Adenocarcinoma Cells Through COX-2 Independent Pathway

(2014) Mahnaz Norouzi et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Clinical Significance of Smoking Cessation in Subjects With Cancer: A 30-Year Review

(2014) A. N. Florou et al.   Respiratory Care

Interleukin-17 Indirectly Promotes M2 Macrophage Differentiation through Stimulation of COX-2/PGE2 Pathway in the Cancer Cells

(2014) Qingli Li et al.   Cancer Research and Treatment

Tobacco, Alcohol, and Cancer in Low and High Income Countries

(2014) Yuan-Chin Amy Lee et al.   Annals of Global Health

Occupational and Environmental Exposures and Cancers in Developing Countries

(2014) Dana Hashim et al.   Annals of Global Health

Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2and PGE3and alteration of Akt phosphorylation

(2013) Peiying Yang et al.   MOLECULAR CARCINOGENESIS

Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma

(2012) Hideki Mizuno et al.   LIVER INTERNATIONAL

PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment

(2011) N. Obermajer et al.   CANCER RESEARCH

Recent clinical developments and rationale for combining targeted agents in non-small cell lung cancer (NSCLC)

(2011) C.P. Belani et al.   CANCER TREATMENT REVIEWS

Functional diversity of the hnRNPs: past, present and perspectives

(2010) Siew Ping Han et al.   BIOCHEMICAL JOURNAL

Combination Effects of Salvianolic Acid B with Low-Dose Celecoxib on Inhibition of Head and Neck Squamous Cell Carcinoma Growth In vitro and In vivo

(2010) Y. Zhao et al.   Cancer Prevention Research

hnRNP A2/B1 Modulates Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines

(2010) J. Tauler et al.   CANCER RESEARCH

Cyclooxygenase-2 in oncogenesis

(2010) Maria Teresa Rizzo   CLINICA CHIMICA ACTA

Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells

(2010) Y Torosyan et al.   ONCOGENE

The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism

(2010) C. V. Clower et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Actin-associated hnRNP proteins as transacting factors in the control of mRNA transport and localization

(2010) Piergiorgio Percipalle et al.   RNA Biology

hnRNP A2 Regulates Alternative mRNA Splicing of TP53INP2 to Control Invasive Cell Migration

(2009) K. Moran-Jones et al.   CANCER RESEARCH

Over-expression of SUMO-1 induces the up-regulation of heterogeneous nuclear ribonucleoprotein A2/B1 isoform B1 (hnRNP A2/B1 isoform B1) and uracil DNA glycosylase (UDG) in hepG2 cells

(2009) Kit Wan Ma et al.   CELL BIOCHEMISTRY AND FUNCTION

Lung cancer and inflammation: interaction of chemokines and hnRNPs

(2009) Jordi Tauler et al.   CURRENT OPINION IN PHARMACOLOGY

Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation

(2008) Yaowu He et al.   MOLECULAR CARCINOGENESIS